13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000950123-25-005707
Total Value
$235.8M
Positions
8
Other Managers
3
Confidential Omitted
No
Holdings (8)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 4,628,225 | $131.2M | 55.65% |
| 2 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $34.1M | 14.45% |
| 3 | Sana Biotechnology Inc | SANA | 15,909,178 | $26.7M | 11.34% |
| 4 | Sana Biotechnology Inc | SANA | 9,092,678 | $15.3M | 6.48% |
| 5 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $12.2M | 5.18% |
| 6 | Seres Therapeutics Inc | MCRB | 14,664,169 | $10.3M | 4.35% |
| 7 | Seres Therapeutics Inc | MCRB | 8,452,876 | $5.9M | 2.51% |
| 8 | Moderna Inc | MRNA | 3,924 | $111,245 | 0.05% |